Post by
ok2buy on May 26, 2021 8:55pm
News
After hours news, company to approach FDA about ending Phase 2a/b trial based on favourable results in enrolled patients. Looking to move to a Phase III study to further address unmet needs with ichthyosis using drug candidate TMB-001. This one could move up tomorrow based on today's news and quickly in the short to mid term to $3. Best of luck to the longs./ok2